Replay available

Zimmer Biomet Holdings, Inc. (ZBH) Q2 2025 Earnings Call

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.

Thu, August 7, 2025 at 8:30 AMendedReplay
Zimmer Biomet Holdings, Inc. (ZBH) Q2 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

David DiMartino

Senior Vice President, Investor Relations

Yvonne Tornos

Chairperson, President, and Chief Executive Officer

Robbie Marcus

Analyst, J.P. Morgan

David Roman

Analyst, Goldman Sachs

Jason Wittes

Analyst, Roth Capital

Larry Beagleson

Analyst, Wells Fargo

Travis Steed

Analyst, Bank of America

Vijay Kumar

Analyst, Evercore ISI

Chris Pasquale

Analyst, Nefron

Ryan Zimmerman

Analyst, BTIG

Patrick Wood

Analyst, Morgan Stanley

Danielle Antolfi

Analyst, UBS

Matt Nixick

Analyst, Barclays

Caitlin Cronin

Analyst, Canaccord

Richard Newiter

Analyst, True Securities

Replay transcript excerpt

Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Second Quarter 2025 Earnings Conference Call. If anyone needs assistance at any time during the conference, please press the star followed by the zero. As a reminder, this conference is being recorded today, August 7, 2025. Following today's presentation, there will be a question and answer session. At this time, all participants are in a listen-only mode. If you have a question, please press the star followed by the one on your push-button phone. I would now like to turn the conference over to David DiMartino, Senior Vice President of Investor Relations. Please go ahead. Thank you, Operator, and good morning, everyone. Welcome to Zimmerblatt Second Quarter 2025 Earnings Conference Call. Joining me on today's call are Don Tornos, our Chairman, President, and CEO of and Sukhya Patia, our CFO in EVP Finance, Operations, and Supply Chain. Before we get started, I'd like to remind you that our comments during this call will include forward-looking statements. Actual results may differ materially from those indicated by the forward-looking statements due to a variety of risks and uncertainties. For a detailed discussion of all these risks and uncertainties, in addition to the inherent limitations of such forward-looking statements, please refer to RICC filings. Please note, we assume no obligation to update these forward-looking statements even if actual results or future expectations change materially. Additionally, the discussions on this call will include certain non-GAAP financial measures, some of which are forward-looking non-GAAP financial measures. Reconciliation on these measures to the most directly comparable GAAP financial measures and an explanation of our basis for calculating these measure...

More from Zimmer Biomet Holdings, Inc.